This article is part of “Innovations In: Alzheimer's Disease” an editorially independent special report that was produced with financial support from Eisai. The first hints that Gregory Nelson might ...

A new blood test that could help doctors identify whether a patient has Alzheimer’s disease was cleared by the FDA last week. The diagnostic tool, the Elecsys pTau 181 plasma test, is developed by ...

A new study suggests that a promising blood test for Alzheimer’s disease may need to be interpreted differently depending on ...

Diagnosing Alzheimer’s disease has long relied on expensive and invasive procedures, often delaying care until symptoms are well advanced. With the recent US Food and Drug Administration (FDA) ...

The U.S. Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other causes of cognitive decline, providing a broader understanding of when the ...

Diagnosing Alzheimer’s, a neurodegenerative disease, is complicated and costly. A study in RI could help speed up the process ...

The increased size of, and lesser blood supply to, a key brain structure in patients with long COVID tracks with known blood ...